Clinical Trial Update: A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS) [Phase 2]

View source ↗

Summary

Phase II clinical trial investigating sintilimab plus chemotherapy followed by concurrent chemoradiotherapy for locally advanced unresectable esophageal squamou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | Phase 2 | Status: RECRUITING